Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
- PMID: 20352408
- PMCID: PMC2877312
- DOI: 10.1007/s00125-010-1702-3
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
Erratum in
- Diabetologia. 2010 Aug;53(8):1813
Abstract
The ADA and the EASD recently published a consensus statement for the medical management of hyperglycaemia in patients with type 2 diabetes. The authors advocate initial treatment with metformin monotherapy and lifestyle modification, followed by addition of basal insulin or a sulfonylurea if glycaemic goals are not met (tier 1 recommendations). All other glucose-lowering therapies are relegated to a secondary (tier 2) status and only recommended for selected clinical settings. In our view, this algorithm does not offer physicians and patients the appropriate selection of options to individualise and optimise care with a view to sustained control of blood glucose and reduction both of diabetes complications and cardiovascular risk. This paper critically assesses the basis of the ADA/EASD algorithm and the resulting tiers of treatment options.
Comment in
-
Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes.Diabetologia. 2010 Jul;53(7):1247-9. doi: 10.1007/s00125-010-1767-z. Epub 2010 Apr 25. Diabetologia. 2010. PMID: 20419286 No abstract available.
-
Should the algorithm for the treatment of type 2 diabetes be evidence-based?Diabetologia. 2010 Sep;53(9):2076-7. doi: 10.1007/s00125-010-1846-1. Epub 2010 Jul 7. Diabetologia. 2010. PMID: 20607513 No abstract available.
-
From authority recommendations to fact-sheets--a future for guidelines.Diabetologia. 2010 Nov;53(11):2285-8. doi: 10.1007/s00125-010-1891-9. Epub 2010 Aug 29. Diabetologia. 2010. PMID: 20803189
-
The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm.Diabetologia. 2010 Nov;53(11):2458-60. doi: 10.1007/s00125-010-1905-7. Epub 2010 Sep 12. Diabetologia. 2010. PMID: 20835856 No abstract available.
-
The combinatorics of medications precludes evidence-based algorithms for therapy.Diabetologia. 2010 Nov;53(11):2456-7. doi: 10.1007/s00125-010-1904-8. Epub 2010 Sep 12. Diabetologia. 2010. PMID: 20835857 No abstract available.
Similar articles
-
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetologia. 2012 Jun;55(6):1577-96. doi: 10.1007/s00125-012-2534-0. Epub 2012 Apr 20. Diabetologia. 2012. PMID: 22526604 No abstract available.
-
Should the algorithm for the treatment of type 2 diabetes be evidence-based?Diabetologia. 2010 Sep;53(9):2076-7. doi: 10.1007/s00125-010-1846-1. Epub 2010 Jul 7. Diabetologia. 2010. PMID: 20607513 No abstract available.
-
Do published ADA studies support the ADA-EASD position statement for the management of hyperglycaemia in type 2 diabetics?Ann Endocrinol (Paris). 2013 Jul;74(3):207-10. doi: 10.1016/j.ando.2013.04.001. Epub 2013 Jun 6. Ann Endocrinol (Paris). 2013. PMID: 23747137
-
Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.Int J Clin Pract Suppl. 2007 Aug;(154):12-8. doi: 10.1111/j.1742-1241.2007.01440.x. Int J Clin Pract Suppl. 2007. PMID: 17593273 Review.
-
Reaching HbA1c goals with saxagliptin in combination with other oral antidiabetic drugs.Postgrad Med. 2010 Jan;122(1):144-52. doi: 10.3810/pgm.2010.01.2108. Postgrad Med. 2010. PMID: 20107298 Review.
Cited by
-
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetologia. 2012 Jun;55(6):1577-96. doi: 10.1007/s00125-012-2534-0. Epub 2012 Apr 20. Diabetologia. 2012. PMID: 22526604 No abstract available.
-
Should the algorithm for the treatment of type 2 diabetes be evidence-based?Diabetologia. 2010 Sep;53(9):2076-7. doi: 10.1007/s00125-010-1846-1. Epub 2010 Jul 7. Diabetologia. 2010. PMID: 20607513 No abstract available.
-
The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm.Diabetologia. 2010 Nov;53(11):2458-60. doi: 10.1007/s00125-010-1905-7. Epub 2010 Sep 12. Diabetologia. 2010. PMID: 20835856 No abstract available.
-
[Current treatment of type 2 diabetes].Internist (Berl). 2012 Dec;53(12):1399-410. doi: 10.1007/s00108-012-3203-6. Internist (Berl). 2012. PMID: 23179598 German.
-
Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors.Diabetologia. 2012 Oct;55(10):2848-2849. doi: 10.1007/s00125-012-2635-9. Epub 2012 Jul 7. Diabetologia. 2012. PMID: 22772765 No abstract available.
References
-
- Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006;49:1711–1721. doi: 10.1007/s00125-006-0316-2. - DOI - PubMed
-
- Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52:17–30. doi: 10.1007/s00125-008-1157-y. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous